Raphael, Michael

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Rha, S. Y., Oh, D.-Y., Yañez, P., Bai, Y., Ryu, M.-H., Lee, J., Rivera, F., Alves, G. V., Garrido, M., Shiu, K.-K., et al. (2023) · The Lancet Oncology

Gastric Cancer Management and OutcomesCancer Immunotherapy and Biomarkers

Cited by 690

Long-Term Mental Health Service Utilization Among Survivors of Testicular Cancer: A Population-Based Cohort Study

Raphael, M. J., Gupta, S., Wei, X., Peng, Y., Soares, C. N., Bedard, P. L., Siemens, D. R., Robinson, A. G., & Booth, C. M. (2021) · Journal of Clinical Oncology

Cancer survivorship and careChildhood Cancer Survivors' Quality of Life

Cited by 34